48-Hour Transdermal Buprenorphine Induction to Initiate Extended-Release Buprenorphine for the Management of Opioid Use Disorder in an Outpatient setting: A Retrospective Case Series
Alaa Al Hawamdeh, MD, Research Coordinator, Medical Doctor, Vancouver General Hospital
7-Hydroxymitragynine Dependence with Severe Functional Impairment: Rapid Stabilization on Buprenorphine/Naloxone
Jason Della Vecchia, MD, Owner, Fresh Start Medicine
A Novel Intervention for Opioid Overdose Survivors: Engaging and Retaining in Treatment
Li Li, MD, Professor, University of Alabama at Birmingham
A Qualitative Study on the Experiences, Barriers, and Understanding of Opioid Agonist Treatment Among Youth with Opioid Use Disorder in Vancouver, British Columbia
Hannah Schneiderman, MD
I Heard My Story: A Qualitative Study of Recovery Experiences in Crystal Meth Anonymous
Julia Steigerwald Schnall, Medical Student, Weill Cornell Medicine/NewYork-Presbyterian Hospital
Accelerated Resolution Therapy as an Adjunctive Treatment Modality for Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder: A Scoping Review
Jaqueline Campbell, MD, Resident, Tripler Army Medical Center
Acceptability and Feasibility of Optimo (Onsite Ptsd Treatment to Improve MOUD Outcomes): An Open Label Pilot of Adapted Cognitive Processing Therapy Delivered at Syringe Services Programs
Teresa Lopez-Castro, PhD, Associate Professor, The City College of New York, CUNY
Acute Psychosis and Opioid Withdrawal Associated with 7-Hydroxymitragynine Use: A Case Report
Nicole Lord, MD, Psychiatry Resident, Northwell Health
Addictions Psychiatry Didactic & Simulation: A Best Practice Teaching Pilot
Marc Hem Lee, MD, Fellow, Massachusetts General Hospital & Harvard Medical School
Age-Specific Substance Use Trends in the United States, 2015-2024: Is the Greatest Burden Still among Younger Adults?
Dania Mofleh, MD, PGY-4 Resident Adult Psychiatry
Alcohol Use Disorder and Binge Eating as Maladaptive Coping Strategies in a Young Adult with Autism Spectrum Disorder: A Case Study in the Complexity of Addiction at the Neurodevelopmental Interface
Majd Al-Soleiti, MD, Psychiatry Resident, Mayo Clinic
Alterations in Muscarinic Acetylcholine Type-1 Receptors in People with Cocaine Use Disorder
Alejandra Pulido Saavedra, MD, Postodoctoral Associate, Yale University
Association between Cannabis-Related Disorders and Incident Psychosis in Individuals with Adhd
Christian Nolan, Medical Student, Howard University College of Medicine
Association between Methadone Dose and Long-Term Retention in Patients Using Fentanyl
Zachary Bosshardt, MD, Psychiatrist, Contra Costa Regional Medical Center
Associations between Cumulative Adversity and Quality of Life: The Roles of Substance Use and Post-Traumatic Stress among People Experiencing Homelessness
Ethan Faries, MD, Psychiatry resident, University of Texas Health Science Center
Behind the Screen: How Social Media Can Help Treat Adolescent Substance Use Disorders
Pantea Farahmand, MD, NYU Langone Medical Center
Beyond Naloxone: A Hospital-Wide Harm Reduction Training Improves Resident Physician Knowledge, Confidence, and Attitudes Across Specialties
Samantha Getsin, MD, Resident, Staten Island University Hospital – Northwell
Beyond the Biomarker: Structural and Linguistic Equity in Fitness-To-Drive Medical Assessment via Dichotomous Questionnaires
Cristian Palmiere, MD, CURML/UMPT
Beyond Weight Loss: GLP- 1 Receptor Agonists for Alcohol Use Disorder- A Systematic Review and Meta-Analysis
Ramita Goel, MD, Resident, Billings Clinic
Bone Health Outcomes Among Patients with Opioid Use Disorder: Buprenorphine vs. Methadone Across Two Complementary Analyses
Claire Drotman, DO, Internal Medicine/Psychiatry Resident Physician, Medical University of South Carolina
Bridging the Gap: Embedding Addiction Counselors in Inpatient Care to Improve Transitions of Care for Patients with Opioid Use Disorder (OUD)
Ann Brandt, Behavioral Health Project Manager, The University of Kansas Health System
Cannabis Use and Psychosis: A Case Series Highlighting Risk Factors for Schizophrenia-Spectrum Disorders.
Emily Waller, MD, MPH, Resident Physician, University of Arkansas for Medical Sciences
Cannabis Withdrawal Symptoms Can Occur Rapidly, be Severe and Bothersome, and Lead to Relapse in Daily/Near Daily Cannabis Users: Results of a Quantitative Cannabis User Survey
Shelli Graham, PhD, Senior VP, Medical/Clinical Research, PleoPharma, Inc.
Case Report: Transition from High-Dose Methadone to Buprenorphine over 14 Days on a Standard Medical Inpatient Unit
Gloria Pereira, MD, Psychiatry Resident, PGY-3, Montefiore
Changes in Knowledge, Attitudes, and Perceptions about Substance Use among Early Middle School Students after Introduction of Substance Use Prevention Curriculum: A Pilot Study
Meredith Nastruz, DO, University of South Dakota, School of Medicine
Characterizing Causal Genetic Relationships among Substance Use, Psychiatric, and Physical Health Disorders
Yousef Khan, MD, PGY1, Neuroscience Research Training Program of the Residency in Psychiatry, Yale University
Childhood Trauma and Motives for Cannabis Use in Individuals with Psychosis
Yousef Khan, Postgraduate Research Associate, Yale School of Medicine
Comparative Analysis of State Policy Responses to Emerging Adulterants Xylazine and Medetomidine
Blessed Sheriff, MD, Resident, Washington VA Medical Center/Georgetown University
Comparative Efficacy of Pharmacological Interventions for Benzodiazepine Discontinuation: A Systematic Review and Network Meta-Analysis
Henrique Oliva, MD, PhD, Psychiatry Resident, Yale University School of Medicine Department of Psychiatry
Contingency Management for Cannabis Use during Pregnancy: A Narrative Review.
Olamide Idowu, aspiring medical student
Convergence of Suicide Attempts, Nonsuicidal Self-Injury, and Substance Use in Adolescents: A Retrospective Study of an Outpatient Substance Use Treatment Population
Muhammet Celik, MD, Psychiatry resident, New York Medical College
Cracking the Black Box of the Illicit Drug Supply: Clinically Relevant Insights from Drug Checking Data in San Diego
Joseph Friedma, MD, MPH, PhD, Resident Physician, UCSD
Cumulative Adverse Childhood Experiences and Patterns of Healthcare Utilization among California Adults: A State-Representative Analysis
David Wiercigroch, MD, FRCPC, Addiction Psychiatry Fellow, Centre for Addiction & Mental Health, Centre for Addiction and Mental Health, University of Toronto
Designing a Contingency Management App to Support Opioid Agonist Therapy
Jade Wong, Researcher, University of British Columbia, Vancouver General Hospital
Detangling a Complex Network: A Framework and Components for Comprehensive Naloxone Community Distribution
Carrie Mills, MPH, PhD, Senior Manager Real World Evidence, Emergent BioSolutions
Effect of Tetrahydrocannabinol on Neural Reward Receipt in Young Adult Cannabis Users: A Randomized, Placebo-Controlled Study
Dominic Grisafe, MD, PhD, Resident Psychiatrist, University of Illinois at Chicago
Effect of L-Cysteine Supplementation on Acetaldehyde Exposure following Ethanol Administration: A Systematic Review and Meta-Analysis
Lucas Heilbroner, Medical Student at GW SMHS, going into Psychiatry
Effects of Alcohol Use on Cognition During Later Adulthood
Shivani Raman, MD, MPH, Resident Physician, UT Southwestern Medical Center
Enhancing Psychiatry Resident Readiness for Management of Addiction Consults on Call
Alexandra Schulz, MD, MS, Resident Physician, NYU Langone Medical Center
Expanding the Therapeutic Landscape of Alcohol Use Disorder: Brenipatide (Dual GIP/GLP-1 Receptor Agonist) Clinical Trials
Marc Fishman, MD, Medical Director, Maryland Treatment Centers
Extreme Sports and Its Association with Substance use: A Scoping Review
Matin Narimani, Research Assistant, Vancouver General Hospital
Feasibility of Multimodal In Vivo Assessment of Psilocybin in Opioid Use Disorder: A Case Series
Julia Shatalov, Research Assistant, Yale School of Medicine, Dept of Psychiatry
Filling the gap in the adolescent substance use care continuum with thoughtful conversations
Linda DeMasi, MA, MBA, Senior Program Manager, Northwell Health
From Methadone 200 mg/day to Brixadi: Successful Inpatient Transition Using Low-Dose Buprenorphine Induction for Persistent QTc Prolongation
Michelle Williamson, MD, Dr, Albert Einstein College of Medicine and Montefiore Medical Center
From Opioid Avoidance to Kratom Dependence: Treatment of Kratom Use Disorder with Long-Acting Injectable Buprenorphine
Alejandro Lopez, MD, Resident physician, NYCHHC at Lincoln Medical and Mental Health Center
GLP-1 Receptor Agonists in Alcohol Use Disorder: Outcome-Domain Synthesis With Exploratory Aggregate-Data Pooling of Randomized Trials
Mahnoor Waqar, MD, Resident, UConn Psychiatry Residency at MMH
Hallucinogen Persisting Perception Disorder In An Adolescent: A Case Report
Phil Dohn, MD, Resident Physician, University of South Dakota
Hidden in Plain Sight: Cocaine Induced Midline Destructive Lesions Misdiagnosed as Granulomatosis with Polyangiitis in a High Functioning Patient with 40 Years of Concealed Cocaine Use
Angelica DiLorenzo, MD, Resident, University of Miami/ Jackson Health System
High-Potency Cannabis as a Modifiable Risk Factor for Cannabis-Induced Psychosis in Adolescents and Young Adults
Sophia Azmi, MPH, Medical Student, West Virginia School of Osteopathic Medicine
Impact of Cannabis Legalization on Emergency Department Visits, Cannabis-Induced Psychosis, and Psychiatric Outcomes: A Community Hospital Analysis
Jaskaran Singh, MD, Resident Physician, Nassau University Medical Center
Importance of Aggressive Early Treatment of Medetomidine Withdrawal
Kiana Malta, MD, Physician, University of Massachusetts Medical Center
"Improving Identification and Treatment of Substance Use Disorders in Inpatient Psychiatry"
Sean Woytowitz, MS4, Keck School of Medicine of USC
Improving Understanding and Reducing Barriers to Utilizing Varenicline for Smoking Cessation Treatment through Accessible Infographic
Huailin Zhang, MD, Fellow Physician, Case Western Reserve University, University Hospitals
Impulsivity and Alcohol Use in Veterans with Co-occurring AUD and PTSD: Variations Before, During, and after Treatment
Edith Harris, PsyD, Assistant Professor, Stanford University School of Medicine, Department of Psychiatry
Incidence of Precipitated Withdrawal Following Rapid Initiation of Weekly and Monthly Extended-Release Injectable Buprenorphine in Adults With Moderate-to-Severe Opioid Use Disorder Not Currently Receiving Buprenorphine: A Study Protocol
Natalie Budilovsky-Kelley, PharmD, Head of Medical Affairs, Braeburn
Increasing Narcan Prescriptions at Discharge from Inpatient Psychiatry Admission at UConn Health through Implementation of an EMR Clinical Decision Support Alert
Cristina Perez Caro, MD, Resident, University of Connecticut Health Center, Dept of Psychiatry
Integrating Evidence-Based Co-Occurring Disorder Treatment and Wraparound Support in a Massachusetts Adult Treatment Court
Hanaan Osman, MA, Doctoral Student, Department of Counseling and Clinical Psychology, Teachers College, Columbia University, New York, New York
Intravenous Use of Bupropion as a Cocaine Substitute: Examining its Acute Clinical Effects in a Psychiatric Crisis Center
Dennis Grapsas, MD, Resident, Jefferson Einstein Philadelphia Hospital
Is There a Relationship between Rising ADHD Diagnoses and Methamphetamine Use Patterns?
Rachel Aniston, Mentee Researcher, Soul Klinic
Kratom and 7OH: The 5th Wave of the Opioid Crisis
Arthur Robin Williams, MD, Associate Professor, Columbia University
Laissez Les MOUD Rouler: Laying the Foundation for Emergency Department Buprenorphine Expansion in Louisiana Using the Bridge Starts Curriculum
Jordan Brandt, MPP, National Program Manager, The Bridge Center
Large Language Models Applied to Admissions Data May Identify Patients at High Risk for Alcohol Withdrawal Syndrome
Natalie Swartz, MD, Psychiatry resident, Stanford Psychiatry
Latent Psychiatric Subtypes and Treatment Outcomes in Opioid Use Disorder: A Secondary Analysis of CTN-0094
Tobias Atkin, MD, Addiction Psychiatry Fellow, Columbia University/New York State Psychiatric Institute
Learning Outcomes and Student Satisfaction in Motivational Interviewing Training: Real Patient versus Artificial Intelligence Mock Patient Experience
Baris Ors, MD, Resident Doctor, Maimonides Health
Legal, Intoxicating and Safe: A Pre-Prohibition Content Analysis of Hemp-Derived Novel Cannabinoid Marketing
Muhammad Youshay Jawad, MD, Psychiatry Resident, Penn State University College of Medicine
Life-Threatening Cardiotoxicity from Chronic High-Dose Loperamide Misuse: A Case Report
Gulcan Yildiz, MD, Resident Physician, Vanderbilt University Medical Center
Mapping the Opioid Crisis: County-Level Hotspots, Cold Spots, and the Geographic Divide in U.S. Overdose Mortality (2021-2023)
Snehitha Reddy Madini, PharmD, Graduate Research Assistant, University of Wisconsin-Milwaukee
Mechanisms and Durability of Residential Treatment for Co-Occurring Gambling and Substance Use Disorders: A Mixed-Methods Eight-Year Follow-Up Study
Jonah Im, Graduate Student Researcher, University of California, Los Angeles
Medetomidine? What Happened to Xylazine?!?! A Case Example from Philadelphia and Literature Review
Paul Grey, DO, PGY5 Addiction Psychiatry Fellow, Thomas Jefferson University
Medical Cannabis Knowledge and Clinical Readiness Among U.S. Medical Students
Nana Yaw Siriboe, Medical Student, Emory University School of Medicine
Methadone Effect on Mood Compared to Other Opioid Agonist Therapies in Patients with Opioid Prescriptions: A Systematic Literature Review and Meta-Analysis
Alyssa Xiong, Research Assistant, University of British Columbia
Methylene Blue’s Clues: Misuse, Mania, and Malignant Catatonia
Joshua Rhudy, MD, Addiction Psychiatry Fellow, West Virginia University Health Sciences Center
Moderated and Unmoderated Digital Recovery Communities for Substance Use Disorders: A Systematic Review
Rameshwari Prasad, MPH, Graduate assistant, The University of Memphis
Multivariable Prediction of Domain-Specific Reward Availability in Opioid Use Disorder: Mindfulness, Loneliness, and Sleep Quality as Independent Psychological Correlates
Arnav Garyali, Medical Student, Baylor College of Medicine
"National Trends in Management of Alcohol Withdrawal Syndrome across Vha following the Implementation of a Toolkit"
Brian Fuehrlein, MD, PhD, Associate Professor of Psychiatry, Yale University, VA Connecticut
Ocular Complications, Withdrawal, and Successful Naltrexone Treatment in Kratom Use Disorder: A Case Report
Yazmine Krentsa, DO, MPH, Resident Physician, Hackensack University Medical Center
Online Sports Betting and Gambling Risk in Brazil: Nationally Representative Findings and Implications for Addiction Psychiatry
Daniel Heringer, MD, Psychiatry Resident, Cleveland Clinic
Optimizing Outreach and Engagement for Substance Use Disorder Training: An Analysis of Opioid Response Network (ORN) Strategies to Enhance Public Health Priorities
Nic Canning, Communications Director, Opioid Response Network, AAAP
Person-First Language in Statues for Commitment for Involuntary Substance Use Disorder Treatment
Oliver Fox, MD, Resident Psychiatrist, Medical University of South Carolina, Department of Psychiatry
Posttraumatic Stress Symptoms, Medical Cannabis, and Pain Outcomes among Adults Prescribed Opioids
Sean Lynch, MD, Addiction Psychiatry Fellow, Columbia University/New York State Psychiatric Institute
Predictors of Buprenorphine Retention following Emergency Department-Initiated Opioid Use Disorder Program
Haley Kvarnberg, Medical Student, University of Alabama at Birmingham Heersink School of Medicine
Predictors of Prolonged Boarding and Short-Term Psychiatric Emergency Service Revisits Among Veterans
Khaled Draghmeh, MD, Postdoctoral Associate, Yale School of Medicine
Predictors of Readmission Following Inpatient Detoxification and Rehabilitation: The Role of Prior Treatment Utilization
William Fletes, MD, Resident - PGY4, Mount Sinai Behavioral Health Center
Pregabalin: A True Dual Diagnosis Medication? Perspectives from a Case of Successful Treatment with Pregabalin in a Patient with Comorbid Alcohol Use Disorder, Anxiety, and Primary Insomnia
Lindsey d'Arnaud, MD, Fellow, Indiana University School of Medicine
Psilocybin Use, Mental Health Treatment Utilization, and Unmet Treatment Need Among US Individuals with Depression
Avery Eun, Medical Student, UC San Diego School of Medicine
Psychiatric Destabilization following Bufo (5-MeO-DMT) Exposure in a Patient with Pre-Existing PTSD: A Case Report
Sabrina Chen, Medical student, University of New England College of Osteopathic Medicine
"Psychosis or Encephalopathy? Addiction Psychiatry Challenges in Co-Occurring
Schizophrenia, Alcohol Use Disorder, and Decompensated Liver Disease"
Fnu Shashi Kant, MD, Research Fellow, Cleveland Clinic Foundation
Real-World Treatment Patterns of Patients Initiating Pharmacotherapy for Alcohol Use Disorder across Medicare, Medicaid, and Commercial Insurance
Valentine Pascale, PharmD, Director Medical Affairs, Knoa Pharma LLC, Stamford, CT
Recent Cocaine Use as a Predictor of 12-Month Treatment Engagement among Women Receiving Methadone Maintenance Treatment
Shai Smith, Medical Student, University of Chicago Pritzker School of Medicine
Recent Rapid Induction Techniques in Patients Transitioning from Methadone to Buprenorphine
Peter Wilson-Braun, DO, Psychiatry Resident PGY3, Baystate Medical Center
Recovery Capital Better Predicts Favorable Discharge Than Psychiatric Symptom Severity in Residential SUD Treatment
Charles Rabinovich, Director of Data, Research & Strategy, Arista Recovery
Recurrent Cannabis Withdrawal-Associated Psychosis: A Case Report
Itamar Shapira, MD, Resident Psychiatrist, UT Austin Dell Medical School
Resident-as-Teacher on the Addiction Psychiatry Consult-Liaison Service
Brittany Bamberg, MD, Resident physician, University of Nebraska Medical Center
Reversible Cardiogenic Shock and Multiorgan Dysfunction Following 7-Hydroxymitragynine Overdose in an Adolescent: A Case Report
Alec Pupo, DO, PGY-2 Psychiatry resident, Delaware Psychiatric Center
Serious Mental Illness and Substance Use Disorders: A National Analysis of Treatment Asymmetry in Dual Diagnosis Populations (2021â2024)
Sergio Muttio Hernandez, MD, Resident Physician, University of Miami / Jackson Health System
Severe Gambling Disorder Precipitated by Compounded Cyp Inhibition from Kratom and an Ssri in a Patient on Low-Dose Aripiprazole: A Novel Three-Way Pharmacokinetic Interaction
Zakariya Irfanullah, MD, Attending Psychiatrist, Berkshire Health Systems
Sex Differences in Pain Relief as the Primary Motivation for Prescription Pain Reliever Misuse among U.S. Adults, 2015-2024
Soohyun Joe, MD, Fellow, Hackensack Meridian Hospital, Jersey Shore University Medical Center
Short- And Long-Term Methadone Dose Trajectories in Patients Testing Positive versus Negative for Fentanyl at Treatment Initiation
Yilang Tang, MD, Director of the Addiction Psychiatry Fellowship Program, Emory University School of Medicine
Short-Term Use of Kratom Resulting in Severe Hyponatremia: A Case Report.
Neha Agrawal, MD, Resident (PGY-4), Charleston Area Medical Center
Single and multiple tobacco product use among people with mental illness and substance use disorders: Findings from the National Surveys on Drug Use and Health, 2022-2024
Kelly Peck, PhD, Associate Professor, University of Vermont
Single-Dose 7-Hydroxymitragynine Induced Psychosis and Delirium Requiring Intensive Care
Jovesh Zachariah, MD, Psychiatry Resident, OUHSC
Sleep as a Treatment Target in Stimulant Use Disorder: Clinical Features and Emerging Therapies
Mert Karatas, MD, Research Associate, University of Utah, Molecular Medicine Program
Substance Use Burden and Psychiatric Readmission following Long-Acting Injectable Antipsychotic Initiation
Angelo Chaia, MD, Resident, Mount Sinai Behavioral Health Center
Substance Use Patterns and Clinical Complexity as Predictors of Psychiatric Readmission among Inpatients Receiving Long-Acting Injectable Antipsychotics
Kathryn Renard, MD, Addiction Psychiatry Fellow, NYU Langone
Substance Use Treatment Characteristics and Outcomes in U.S. General Psychiatry Residency Programs, 2015-2025
Sidarth Wakhlu, MD, Professor of Psychiatry Distinguished Teaching Professor Interim Chief Addiction Division Addiction Psychiatry Fellowship Director Chair, Student Assistance Committee Member, Medical School Admissions Committee UT Southwestern Medical Center Professor of Clinical Sciences TCU Burnett School of Medicine, UT Southwestern Medical Center
Successful Treatment of a Patient with Severe 7-OH Abuse and Chronic Psychosis.
Jenna Dolan, MD, Addiction Psychiatry Fellow, University of Washington
Supplementary Pathway for Medically Monitored Ibogaine for Opioid Use Disorder: A National Semi-Markov Cost-Effectiveness Analysis
T Wagner, Medical Student, Perelman School of Medicine University of Pennsylvania
The Effects of Neuromodulation of craving, abstinence, mood, and Neurobiological Outcomes in Cocaine Use disorder: A Meta-Analytic Review
Manvir Bhangu, Medical Student, McMaster University
The Hottest Topic of Our Time: A Literature Review and Call to Action on Rising Heat and Substance Use Disorders
Alexa Hooberman, MD, Addiction Psychiatry Fellow, University of Massachusetts
The Opioid Response Networks Naloxone and Saturation Mapping Training for Tribes
Johnna James, Director of Community Health Initiatives for the Opioid Response Network, AAAP
The Socioeconomic Paradox of Substance Use: High Income and Education as Independent Risk Factors for Alcohol Use Disorder in U.S. Adults (2021-2024)
Dania Mofleh, MD, PGY-4 Resident Adult Psychiatry
Trends in Buprenorphine Prescribing by Provider Type and Patient Race in a Large Academic Health System, 2020-2025
Chaden Noureddine, MD, Resident, Icahn School of Medicine At Mount Sinai
Understanding the Trends in the National Survey on Gambling Attitudes and Gambling Experiences (NGAGE) across the Three Versions of the Survey
Tyler Kung, Medical Student, Beebe Healthcare/PCOM
Unsupervised Anabolic Steroid Use in a Patient on Methadone Maintenance Therapy: A Case Report Highlighting Gaps in Care Coordination and the Role of Addiction Psychiatry
William Jangro, DO, Clinical Associate Professor, Thomas Jefferson University
Use of Diazoxide in Management of Methadone-Induced Hypoglycemia
Morgan Barnett, DO, Resident Fellow, OHSU
Virtual Reality-Based Psychedelic-Like Perceptual Alterations
Yalda Farahmand, MD, Postdoctoral Associate, Yale University School of Medicine
What is SR-17018? A Literature Review and Social Media Analysis of Real-World Use
Sarah Cheema, MD, Resident Physician, Baylor College of Medicine
When Muscle Relaxation Unravels: A Case of Tizanidine Withdrawal
Claudia Cruz, MD, Psychiatry Resident, Department of Psychiatry, Vanderbilt University
When Psychiatry Changes the Stroke Workup: Nitrous Oxide Associated Mixed Arterial and Venous Thrombosis Presenting as Recurrent Stroke and Central Auditory Dysfunction
Mashal Jamil, MD, Resident Psychiatrist, Department of Psychiatry, Corewell Health William Beaumont University Hospital, Royal Oak